4//SEC Filing
Taylor John Clayton 4
Accession 0001415889-23-001854
CIK 0000861838other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:06 PM ET
Size
5.9 KB
Accession
0001415889-23-001854
Insider Transaction Report
Form 4
Aceragen, Inc.ACGN
Taylor John Clayton
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-01-20+74,500→ 74,500 totalExercise: $5.21Exp: 2033-01-20→ Common Stock (74,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2022 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 20, 2023. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 20, 2024 (first anniversary of the date of grant) and the balance vests in thirty-six equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Aceragen, Inc.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001947029
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:06 PM ET
- Size
- 5.9 KB